InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Sepp-Lorenzino Laura, Directeur Scientifique. Insider active across 3 companies, notably Intellia Therapeutics, Inc.. Cumulatively, 14 reports have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €386k. Activity tracked since 4 August 2021. The latest transaction was filed on 2 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Sepp-Lorenzino Laura
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
56,623 股0Common StockSEC:0001415889-25-015571:0
8,966 股@ US$12.186.7% 占其流量Common StockSEC:0000950170-25-003002:0
3,500 股Common StockSEC:0000950170-25-001232:0
49,220 股0Common StockSEC:0001415889-24-015038:0
37,966 股0Common StockSEC:0000950170-24-025907:0
1,608 股@ US$28.662.7% 占其流量Common StockSEC:0000950170-24-003632:0
5,532 股@ US$29.469.4% 占其流量Common StockSEC:0000950170-24-002514:0
3,500 股Common StockSEC:0000950170-24-001210:0
29,938 股0Common StockSEC:0001209191-23-015742:0
2,508 股@ US$37.215.6% 占其流量Common StockSEC:0001209191-23-002433:0
3,500 股Common StockSEC:0001209191-23-001498:0
3,500 股Common StockSEC:0001209191-22-015976:0
27,000 股@ US$13.4031.1% 占其流量Common StockSEC:0001209191-21-054321:0
26,000 股@ US$13.4029.8% 占其流量Common StockSEC:0001209191-21-050228:0
14 条申报中的 14 条
About Sepp-Lorenzino Laura
Sepp-Lorenzino Laura is Directeur Scientifique. She has 14 filings in total, and across the 14 most recent filings we hold, the sell amount totals EUR 385900, with no buys, between 2021-08-06 and 2025-06-04. The listed companies are Intellia Therapeutics, Inc., where she is EVP, Chief Scientific Officer, and Taysha Gene Therapies, Inc., where she is Director.
